title: Metabolic syndrome criteria: ready for clinical prime time or work in progress?
authors.forename: Naveed
authors.initials: N
authors.lastname: Sattar
authors.forename: Nita G
authors.initials: NG
authors.lastname: Forouhi
mesh_terms: D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000150:complications*; D017035:Pravastatin / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin